Skip to content

Clinical trials

Schizophrenia trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Austria Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20044
20052
20072
20083
20104
20115
20121
20131
20151
20161
20172
20181
20211
20221
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Not yet recruiting3
Terminated3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Medical University of Vienna4
Boehringer Ingelheim3
Denovo Biopharma LLC3
Janssen-Cilag International NV3
Alkermes, Inc.2
Eli Lilly and Company2
Janssen Research & Development, LLC2
Medical University Innsbruck2
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia35
Psychotic Disorders10
Cognitive Dysfunction2
Bipolar Disorder1
Diabetes Mellitus1
Major Depressive Disorder1
Mental Disorders1
Recurrence1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.